These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prevalence of Acinetobacter baumannii in Saudi Arabia: risk factors, antimicrobial resistance patterns and mechanisms of carbapenem resistance. Ibrahim ME Ann Clin Microbiol Antimicrob; 2019 Jan; 18(1):1. PubMed ID: 30606201 [TBL] [Abstract][Full Text] [Related]
3. Antimicrobial Resistance of Acinetobacter baumannii to Imipenem in Iran: A Systematic Review and Meta-Analysis. Pourhajibagher M; Hashemi FB; Pourakbari B; Aziemzadeh M; Bahador A Open Microbiol J; 2016; 10():32-42. PubMed ID: 27099638 [TBL] [Abstract][Full Text] [Related]
4. Accumulation of Antibiotic Resistance Genes in Carbapenem-Resistant Douraghi M; Kenyon JJ; Aris P; Asadian M; Ghourchian S; Hamidian M mSphere; 2020 Apr; 5(2):. PubMed ID: 32269158 [TBL] [Abstract][Full Text] [Related]
5. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients. Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602 [TBL] [Abstract][Full Text] [Related]
6. Dahdouh E; Hajjar M; Suarez M; Daoud Z Front Cell Infect Microbiol; 2016; 6():163. PubMed ID: 27933276 [No Abstract] [Full Text] [Related]
7. Spread of a carbapenem- and colistin-resistant Acinetobacter baumannii ST2 clonal strain causing outbreaks in two Sicilian hospitals. Agodi A; Voulgari E; Barchitta M; Quattrocchi A; Bellocchi P; Poulou A; Santangelo C; Castiglione G; Giaquinta L; Romeo MA; Vrioni G; Tsakris A J Hosp Infect; 2014 Apr; 86(4):260-6. PubMed ID: 24680473 [TBL] [Abstract][Full Text] [Related]
8. Emergence, molecular mechanisms and global spread of carbapenem-resistant Hamidian M; Nigro SJ Microb Genom; 2019 Oct; 5(10):. PubMed ID: 31599224 [No Abstract] [Full Text] [Related]
9. Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period. Jasemi S; Douraghi M; Adibhesami H; Zeraati H; Rahbar M; Boroumand MA; Aliramezani A; Ghourchian S; Mohammadzadeh M Lett Appl Microbiol; 2016 Dec; 63(6):466-472. PubMed ID: 27626896 [TBL] [Abstract][Full Text] [Related]
10. Systematic Review and Meta-analysis of Carbapenem Resistance of Acinetobacter baumannii in Iran. Shakib P; Choolandaimy ZB; Rezaie F; Bahmani M; Delfani S Infect Disord Drug Targets; 2020; 20(5):611-619. PubMed ID: 31566141 [TBL] [Abstract][Full Text] [Related]
11. Prevalence and Mechanisms of Carbapenem Resistance in Nasiri MJ; Zamani S; Fardsanei F; Arshadi M; Bigverdi R; Hajikhani B; Goudarzi H; Tabarsi P; Dabiri H; Feizabadi MM Microb Drug Resist; 2020 Mar; 26(3):270-283. PubMed ID: 30822197 [No Abstract] [Full Text] [Related]
12. Multi-drug resistance of blood stream, urinary tract and surgical site nosocomial infections of Acinetobacter baumannii and Pseudomonas aeruginosa among patients hospitalized at Felegehiwot referral hospital, Northwest Ethiopia: a cross-sectional study. Motbainor H; Bereded F; Mulu W BMC Infect Dis; 2020 Jan; 20(1):92. PubMed ID: 32000693 [TBL] [Abstract][Full Text] [Related]
14. Identification of multidrug- and carbapenem-resistant Acinetobacter baumannii in Canada: results from CANWARD 2007. McCracken M; DeCorby M; Fuller J; Loo V; Hoban DJ; Zhanel GG; Mulvey MR J Antimicrob Chemother; 2009 Sep; 64(3):552-5. PubMed ID: 19578083 [TBL] [Abstract][Full Text] [Related]
15. Carbapenem resistance in Acinetobacter baumannii: the molecular epidemic features of an emerging problem in health care facilities. Zarrilli R; Giannouli M; Tomasone F; Triassi M; Tsakris A J Infect Dev Ctries; 2009 Jun; 3(5):335-41. PubMed ID: 19759502 [TBL] [Abstract][Full Text] [Related]
16. Molecular epidemiology and antimicrobial resistance phenotypes of Acinetobacter baumannii isolated from patients in three hospitals in southern Vietnam. Tuan Anh N; Nga TVT; Tuan HM; Tuan NS; Y DM; Vinh Chau NV; Baker S; Duong HHT J Med Microbiol; 2017 Jan; 66(1):46-53. PubMed ID: 28198682 [TBL] [Abstract][Full Text] [Related]
17. High prevalence of carbapenem-resistant Acinetobacter baumannii associated respiratory tract infections in Pakistani hospitals. Khalid F; Saleem S; Ahmad I J Pak Med Assoc; 2020 Sep; 70(9):1630-1632. PubMed ID: 33040124 [TBL] [Abstract][Full Text] [Related]
18. Co-existence of Joshi PR; Acharya M; Kakshapati T; Leungtongkam U; Thummeepak R; Sitthisak S Antimicrob Resist Infect Control; 2017; 6():21. PubMed ID: 28191309 [TBL] [Abstract][Full Text] [Related]
19. A 5-year Surveillance Study on Antimicrobial Resistance of Acinetobacter baumannii Clinical Isolates from a Tertiary Greek Hospital. Maraki S; Mantadakis E; Mavromanolaki VE; Kofteridis DP; Samonis G Infect Chemother; 2016 Sep; 48(3):190-198. PubMed ID: 27659437 [TBL] [Abstract][Full Text] [Related]